The UKAS sent their newsletter today. You can read it by clicking here. I did… I was thinking of writing something witty and sarcastic but UKAS newsletters really are the way forward… for all that I honestly wish they weren’t.
The ASH sent their spotlight on chronic leukaemias today. Perhaps all a bit too clinical for me, but all useful stuff:
There are precious few other biomedical scientists who write a blog like this, and so when one of them posts about something that they themselves have seen first-hand, I for one and going to shamelessly blag their work.
You can read a rather good case study by clicking here. Hypogranular neutrophils were detected from scrutiny of an XN10 plot…
The IBMS sent its “Council and Fellows” newsletter today. As always it was far more about “people” than anything practical, which was a shame.
Whenever anything comes from the IBMS I always seem to be negative about it… What do I actually want from the IBMS? I’m not sure, but I don’t think I am getting it…
The Transfusion Evidence Alert email arrived in my in-box today. Probably (definitely) too much to take in at once, but unusually (at first sight) this lot seems of more peripheral than direct interest. But something for nothing is always worth having…
Top 10 new articles: March 2021
ARTICLE OF THE MONTH
another BTLP-TACT exercise.
I logged in and was (eventually) presented with one case – a twenty year old chap attending the haematology clinic requiring two units of irradiated blood for the following day.
grouped as O Rh(D) Positive, but the D reaction was weak. In reality I would
have sent this off to the transfusion centre (or whatever they are called
these days) to see if this was a weak D or a partial D. In view of that I
called the Rh group uninterpretable.
The antibody screen was negative.
I selected two units of O Rh(D) Negative K Negative blood
I got the green light.
The nice people at the American Society of Hematology sent their update today. As always much of it went over my head, but one bit caught my eye: